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Abstract 
Research in biosensing approaches as alternative techniques for food diagnostics for the 
detection of chemical contaminants and foodborne pathogens has increased over the last 
twenty years. The key component of such tests is the biorecognition element whereby 
polyclonal or monoclonal antibodies still dominate the market. Traditionally the screening of 
sera or cell culture media for the selection of polyclonal or monoclonal candidate antibodies 
respectively has been performed by enzyme immunoassays. For niche toxin compounds, 
enzyme immunoassays can be expensive and / or prohibitive methodologies for antibody 
production due to limitations in toxin supply for conjugate production. Automated, self-
regenerating, chip-based biosensors proven in food diagnostics may be utilised as rapid 
screening tools for antibody candidate selection. This work describes the use of both single 
channel and multi-channel surface plasmon resonance (SPR) biosensors for the selection and 
characterisation of antibodies, and their evaluation in shellfish tissue as standard techniques 
for the detection of domoic acid, as a model toxin compound. The key advantages in the use 
of these biosensor techniques for screening hybridomas in monoclonal antibody production 
were the real time observation of molecular interaction and rapid turnaround time in analysis 
compared to enzyme immunoassays. The multichannel prototype instrument was superior 
with 96 analyses completed in 2 hour compared to 12 hours for the single channel and over 
24 hours for the ELISA immunoassay. Antibodies of high sensitivity, IC50’s ranging from 4.8 
to 6.9 ng/mL for monoclonal and 2.3 to 6.0 ng/mL for polyclonal, for the detection of domoic 
acid in a 1 minute analysis time were selected. Although there is a progression for biosensor 
technology towards low cost, multiplexed portable diagnostics for the food industry, there 
remains a place for laboratory-based SPR instrumentation for antibody development for food 
diagnostics as shown herein.  
 
Introduction 
Awareness of human exposure to a wide range of contaminants through the diet, originating 
from anthropogenic, natural sources and fraudulent practices along the food supply chain has 
been heightened with increasing media attention and consumer cognizance. The food supply 
chain can become contaminated at various points from environment to farm to fork by 
bacteria, viruses or chemicals present in the environment; the improper use of agrichemicals 
such as antibiotics and pesticides; the illegal use of growth promoting compounds in animal 
production; by-products of food processing techniques; and naturally occurring toxins such as 
phycotoxins and mycotoxins. Food contamination can cause serious acute and chronic health 
effects resulting in economic and political repercussions with subsequent “food scares” and 
recalls of products (An et al., 2007; Chen, 2009; Gossner et al., 2009; Holt et al., 1993; 
Hoogenboom et al., 2015; Lewis et al., 2005; McKay and Scharman 2015; Salleras et al., 
1995). In order to monitor food for contamination and to ensure that unacceptable levels do 
not enter the human food chain, it is imperative that products are subjected to scrutiny, in real 
time at critical control points in the chain, and with respect to their safety in an efficient and 
rapid manner.  
In recent years, advances in biosensor and nanotechnology for diagnostics have offered 
solutions, albeit mostly as research tools in portable, multiple analyte diagnostics for small 
numbers of samples. Relatively expensive biosensor technology (e.g., ≥$100K USD) for food 
analysis as a screening tool that is restricted to the laboratory setting is generally no longer 
deemed as cost-effective in comparison to the advances in state-of-the art confirmatory mass 
spectrometry methods for multiple analytes. These biosensors tend to be only suitably cost-
effective when they have the ability to efficiently analyse a large number of samples for the 
presence of multiple chemical contaminants in food matrices with a relatively short 
turnaround time (McGrath et al., 2012). Additionally, biosensors may be used as an 
alternative to mass spectrometry as a way of diversifying resources and skills in a routine 
analytical laboratory, but employing both technologies still remains an innovative challenge.  
Advances over the past two decades have led to the manufacture of a range of 
instrumentation employing a variety of detection principles. Modern biosensors offer the 
ability to be portable devices for regulatory bodies and the food industry alike to verify the 
safety and quality of products intended for human consumption along the food supply chain. 
It is expected that biosensors will have added advantages over traditional technologies, since 
they combine the high affinity of the biochemical interactions, resulting in high sensitivities 
and low limits of detection, with the possible miniaturisation, “point-of-use” portability and 
automation which make them interesting for in situ monitoring (Campas et al., 2007). 
Importantly, as biosensors operate on the principle of measuring a biomolecular interaction of 
two components on a surface, the key component for food analysis still remains the 
biorecognition element for the interaction and detection with the target contaminant. 
Polyclonal antibodies, and more recently monoclonal antibodies that reduce the use of 
animals, still tend to be the most suitable biorecognition elements in commercial 
immunodiagnostics for food analysis. For the production and characterization of 
biorecognition elements, the use of a laboratory based biosensing instrument that operates 
with a high degree of automation, user friendliness, accuracy and precision with real-time 
analysis is a vital tool for the robust screening and characterization of antibody binding and 
matrix performance. 
Surface plasmon resonance (SPR) biosensor technology has been the most successful 
immunosensor to date for food analysis and is primarily employed in a laboratory setting. 
SPR biosensors are affinity, optical sensors where the signal is based on measuring binding-
induced changes in refractive index and this platform thus allows for  label-free, real-time 
analysis (Figure1). Depending on SPR response to the binding of analytes to a surface, an 
analyte can be detected with a direct, sandwich, or inhibition assay. For small analytes 
(molecular weight < 1000 Da), an inhibition assay is often used, where small analytes are 
premixed with antibodies and unbound antibody sites are captured by the small analytes 
immobilized on a sensor surface (Yu et al., 2005). This approach has been used widely with 
SPR biosensors for the detection of aquatic toxins (Campbell et al., 2007; Campbell et al., 
2013; Devlin et al., 2014; Fonfria et al., 2007; Garibo et al., 2014; Reverte et al., 2015; Yakes 
et al., 2011; Yakes et al., 2015). Variations in SPR technology is available with different 
capabilities in analysis due to the utilisation of single or multiple flow channels (Figure 1). 
Therefore, SPR biosensor technology enables simultaneous observations of molecular 
interactions on a surface containing multiple channels offering multiplexed evaluations in a 
single analysis (Campbell et al., 2011; McNamee et al. 2013; Campbell et al., 2014).  
In this research, a Biacore SPR high throughput prototype instrument was employed for 
effective multiplexed analysis for evaluation of the marine toxin, antibody interaction. The 
system is designed primarily for rapid, simultaneous screening of multiple ligands (up to 16) 
by employing a 4 × 4 format with four 0.6 mm2 flow cell areas that each contain four SPR 
sensing spots. This flexible, multichannel format enables assays with either multi-ligand or 
multi-sample focuses. When a Series S CM5 chip with 16 immobilised ligands is docked, 
four independent parallel flow cells are formed by the sensor chip pressing against moulded 
channels on the integrated microfluidic cartridge (IFC), and the response is measured from 
four detection spots in each flow cell (Campbell et al., 2011). Variation in assay design offers 
alternative approaches for antibody selection, characterisation and target analysis which may 
be extremely beneficial when the target analyte is expensive or difficult to source (Campbell 
et al., 2014; Yakes et al., 2014).  
Marine biotoxins are an exemplar case whereby the development of rapid methods including 
antibody-based assays have been restricted due to the limitations in and relatively expensive 
costs of many toxins. In order to investigate SPR biosensor technology for characterizing 
antibodies to small-molecule toxins, the cost-effective and easily obtainable domoic acid 
(DA) toxin is used as a model compound in this study. This neurotoxin is renowned to cause 
amnesic shellfish poisoning (ASP) illness in humans (Iverson and Truelove, 1994; Lelong, 
2012; Scholin, 2000) and is predominately found in bivalve shellfish that filter feed on toxin 
producing diatom of the genus Pseudonitzschia. Thereby, shellfish are regulated with a limit 
of 20 µg DA per gram of tissue in the United States and European Union (US FDA, 2012 and 
EC 2002/226/EC), and monitoring from both a public health perspective and the protection of 
the industry brand from toxic recalls is vital. Recent events, including the November 2015 
closure of U.S. West Coast Dungeness crab harvesting due to high levels of DA in the waters 
and accumulation in the crabs (C&EN 2015), highlight the need for appropriate, rapid 
detection methods. 
To this end, this study aims to demonstrate the (1) development of robust methods for 
antibody production for a small molecular weight toxin, (2) use of SPR biosensor 
technologies for antibody screening and selection and (3) investigate the use of a commercial, 
multi-channel SPR instrument (Biacore T100) for toxin immunoassay development and 
detection in complex matrices. While this work focuses on the model system of DA in 
shellfish matrices, the protocols discussed herein should have applicability to a large number 
of antibody/analyte systems. 
 
 
 
 
 
 
Materials and Methods 
Instrumentation 
An optical SPR Biosensor system (Biacore Q) and a high throughput multichannel prototype 
instrument (Campbell et al., 2011) with Control and BIAevaluation software 4.1 were 
obtained from Biacore AB, GE Healthcare (Uppsala, Sweden). For additional assays, a four-
channel SPR instrument (Biacore T100, GE Healthcare) was employed and controlled via 
Biacore T100 Control software with evaluation via Biacore T100 Evaluation software. 
Further data processing was performed with GraphPad Prism 5 (La Jolla, CA). 
 
Materials 
Biacore Q CM5 and Series S CM5 sensor chips, HBS-EP and HBS-EP+ buffers and amine 
coupling kits were obtained from Biacore AB (Uppsala, Sweden). Domoic acid (DA), 1-
ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC), N-hydroxysuccinimide 
(NHS), bovine thyroglobulin (BTG), 2-(N-morpholino)ethanesulfonic acid (MES), 2,2’-
(ethylenedioxy)bis(ethylamine), L-glutamic acid (GA), L-glutamine (GluNH2), kainic acid 
monohydrate (KA), aspartic acid (AA) and sodium acetate were purchased from Sigma-
Aldrich Company Ltd. (Dorset, UK; St. Louis, MO, USA). The Quil A was from Invivogen 
(France) while the Pam3Cys-Ser(Lys)4-OH (PCSL) was acquired from EMC 
Microcollections, GmbH, (Germany). Isotyping kits (Isostrip) were obtained from Roche 
(UK). Cell culture reagents were obtained from Invitrogen (UK). Borate buffer was procured 
from Pierce (Thermo Fisher Scientific, Rockford, IL, USA). Tetrodotoxin (TTX, Sankyo Co 
Ltd., Tokyo, Japan), saxitoxin (STX, National Institute of Standards and Technology (NIST), 
Gaithersburg, MD, USA), and okadaic acid (OA, National Research Council Canada, Ottawa, 
Ontario) were employed in cross-reactivity studies. All solvents were of LC grade and were 
obtained from Rathburn, Walkerburn, Strathclyde, UK.   
Protein Conjugate Synthesis 
Domoic acid was employed as the model small molecular weight compound to demonstrate 
the capability of the antibody production and instrumentation. Antibodies were raised to 
domoic acid, bovine thyroglobulin (BTG) protein conjugate. In brief, EDC (11.6 mg) and 
NHS (10.6 mg) in MES buffer were added to a solution of DA in 1.0 mL water and mixed for 
15 min at room temperature. BTG (50 mg) was then added to the activated DA solution. The 
reaction mixture was incubated overnight at room temperature before purification by 24 hr 
dialysis against saline (0.15 M sodium chloride). The purified immunogen was diluted with 
saline to a final concentration of 1 mg/mL protein and stored at –20 °C until used. Domoic 
acid, horse radish peroxidase (DA-HRP) was prepared as the reporter for ELISA in a similar 
manner as the BTG protein conjugate for immunisations.  
 
Antibody Production 
Polyclonal antibodies were raised in rabbits by subcutaneous injection with 0.2 mg of the DA 
immunogen emulsified with Freund’s complete adjuvant. Booster injections (0.2 mg of 
immunogen emulsified with Freund’s incomplete adjuvant) were then administered on a 
fortnightly basis for 2 boosters and monthly for a further 3 booster immunisations. Test 
bleeds were collected ten days after each booster injection and monitored for the presence of 
antibodies by the SPR sensor. The antiserum was harvested 28 days after the final booster 
and stored frozen at –20 °C until required.  
For the production of monoclonal antibodies a balb/c mouse was immunised with 0.02 mg of 
immunogen emulsified with Quil A for two immunisations on day 0 and 14. Three further 
booster immunisations (0.02 mg of immunogen emulsified with the adjuvant Pam3Cys-Ser-
(Lys)4 (PCSL)) were then administered on a monthly basis. Test bleeds were collected ten 
days after each booster injection and monitored for the presence of antibodies by the SPR 
sensor. Three days after the fifth immunisation the mouse was sacrificed, and the spleen was 
removed for fusion with an SP2 myeloma cell line to produce monoclonal antibodies (Galfre 
and Milstein, 1981). All protocols for antibody production performed using animals were 
conducted in accordance with a licence issued by the Department of Health, Social Services 
and Public Safety in Northern Ireland, UK under the animal scientific procedures Act 1986. 
 
Biosensor Chip Production 
Domoic acid was immobilised onto the CM5 surface of the sensor chip (Figure 2). Briefly, 
the chip surface was activated by contact with 50 L of a 1:1 mixture of 0.4 M EDC: 0.2 M 
NHS for 20 min. The reactants were removed and 50 L of 2,2’-
(ethylenedioxy)bis(ethylamine) was added and allowed to remain in contact with the sensor 
chip surface for 1 hr; the chip surface was then washed with deionised water prior to the 
addition of 50 L of 1M ethanolamine solution for 20 mins. EDC (1.5 mg) and NHS (0.9 mg) 
were dissolved in 50 µL pH 4.7 MES buffer. This mixture (50 µL) was added to 250 µL of 2 
mg/mL DA in water. An aliquot (50 L) of this reactive mixture was added to the chip 
surface and allowed to react overnight. The chip surface was washed repeatedly with 
deionised water, dried using a stream of nitrogen gas and stored desiccated at +4 °C when not 
in use.  
For the Biacore T100 instrument, a partial in-instrument and partial on-bench coupling 
method was used. Specifically, the Biacore amine kit, standard amine wizard protocol, and 
pH 8.5, 50 mM borate buffer were used to link 2,2’-(ethylenedioxy)bis(ethylamine) to flow 
cells 2-4 with flow cell 1 left as a reference surface (no coupling). Following ethanolamine 
inactivation, the sensor chip was removed and DA was coupled to the surface in the same 
manner as described above. After reacting for 15 hr, the sensor chip was rinsed/dried/stored 
following the same procedure as above. 
Comparison of Hybridoma Screening by SPR biosensors and ELISA 
In SPR biosensor analysis, equal volumes of hybridoma supernatant and HBS-EP pH 7.4 
were mixed and tested for binding to DA immobilised on the chip surface. For a positive 
control, the final mouse bleed, at 1:300 in HAT media, was diluted 1:1 with HBS-EP pH 7.4. 
A negative control was prepared by 1:1 mixing of HAT media with HBS-EP buffer. Samples 
were injected over the chip surface at a flow rate of 20 µL/min for 1 min on both the Biacore 
Q and prototype high throughput Biacore SPR for comparison. The chip surface was 
regenerated after each sample injection with 50 mM sodium hydroxide at a flow rate of 20 
µL/min for 1 min.  
An antigen capture ELISA assay was also utilised for the initial hybridoma screening. In 
brief, 25 µL of hybridoma supernatant were mixed with 75 µL of phosphate buffer pH 7.2, 
and the antibody allowed to immobilise on 96 well Falcon plates overnight at room 
temperature. The media was tapped out and DA-HRP prepared in 0.1% BSA solution was 
added to the plates and incubated at 4 C overnight. The plates were washed ten times with 
ELISA wash solution (0.15 M saline with 0.125% Tween 20). Subsequently, TMB-E 
substrate (100 L) was added, the colour development was stopped after 15 min by adding 50 
L of 2.5 M H2SO4, and the optical densities were read immediately at 450 nm using a Tecan 
Safire plate reader. 
Controls were included within each assay type alternating between negative and positive.  A 
positive was deemed as such for any sample that gave a signal equal or greater than the final 
heart bleed positive control, as lower would be interpreted as non-specific binding. Positive 
binders were further checked for specificity of binding by competition in the assay with and 
without DA (100 ng/mL), where DA specific binders were characterised by a reduction of 
signal when DA was present. Both SPR biosensor and ELISA assays yielded first screen 
hybridomas displaying suitable binding and inhibition. These were then cloned twice for 
single colony selection whereby clones were then selected for antibody production. 
 
Monoclonal Antibody 
On selection of the best monoclonal antibody, the cell line was grown, and antibody was 
concentrated in cell culture media using a CELLine 1000 bioreactor (IBS Integra 
Biosciences, UK), followed by purification via affinity chromatography using a protein G-
sepharose gel column (MAbTrap Kit). Dialysis of the antibody over 24 hours in 0.15 M 
saline (3×4 L) was performed. The protein concentration and isotyping of each monoclonal 
antibody was determined at A280 nm and using a mouse monoclonal antibody isotyping kit 
(Roche Diagnostics), respectively.  
Biosensor Characterisation of Monoclonal and Polyclonal Antibodies with Biacore Q  
Initially, various parameters were investigated in the development of the Biacore Q biosensor 
assay including: binder dilution, ratio of binder to standard, injection volume, and contact 
time. The final assay consisted of: 1:200 antibody in HBS-EP mixed with the sample, contact 
time of 60 s with 15 s dissociation, regeneration with 50 mM HCl with 0.5% SDS for 60 s, 
flow rate of 25 µL/min, and analysis temperature at 25 °C. Prior to use, the sample chip was 
conditioned via the regeneration solution for three cycles. The sensitivity of the monoclonal 
antibody to DA was assessed using the Biacore Q biosensor. A stock solution of DA (1 
mg/mL) was prepared and calibrants at 0, 1, 2.5, 5.0, 10, 25 and 100 ng/mL were prepared in 
pH 7.4 HBS-EP buffer. These working standards were used to produce calibration curves 
based on dose-response of the biosensor to compare the antibody performance. 
 
 
 
Transferability to a Biacore T100 Assay 
The monoclonal antibody showing the best sensitivity on the Biacore Q instrument was 
evaluated in higher-throughput assays for the detection of domoic acid in shellfish on the 
commercial, Biacore T100 instrument. Previous studies have shown that the Q and T100 
instrumentation, while having variations in surface formation and sensor response, allow for 
ease of method transferability (Haughey et al. 2011). For the Biacore T100 inhibition assay, 
assay parameters were adjusted to be consistent with the Biacore Q assay as outlined 
previously. In the Biacore T100 assay, varying dilutions of binder were evaluated to explore 
the maximum response and sensitivity of the assay.  
 
Cross-reactivity 
The cross-reactivity of seafood toxins that coexist with DA (e.g., TTX, STX, and OA) and 
compounds that have similar chemical structure to DA (e.g., GA, GluNH2, KA, and AA) 
were evaluated. Ten-fold dilutions in buffer of 10,000 ng/mL of each compound down to 0.1 
ng/mL were analysed with the anti-DA and SPR assay on the Biacore T100. The curves were 
fit, and cross-reactivity was determined from a comparison of the IC50 values for each toxin 
curve to the DA standard curve IC50. Additionally, each cross-reactor at 1000 ng/mL was 
tested with the addition of 9.9 ng/mL DA to determine if additive or subtractive effects were 
present in these mixtures.  
 
Matrix Evaluation 
DA is a known contaminant of shellfish (Tasker 2015). To further develop the assay, shellfish 
matrices were prepared and spiked with DA to evaluate assay performance. Specifically, a 
modified NSSP method was used for the preparation of shellfish samples (AOAC Official 
Method 2006.02). First, 4 mL of methanol in water (50% (v/v)) was added to 1 g of 
homogenized shellfish tissue (aliquoted from a pool of 12 homogenized organisms). For the 
recovery evaluation, 20 g DA (20 L of 1 mg/mL standard) was added to the homogenized 
tissue, the sample briefly vortex, and then allowed to sit for 2 min prior to addition of the 
solvent. Following a 1.5 min vortex, each sample was roller-mixed for 30 min and then 
centrifuged at 3000 ×g for 10 min at room temp. The supernatant was decanted and used for 
further studies with 5 µL supernatant added to 1995 µL HBS-EP+ for the Biacore T100 
assay. 
 
Results and Discussion 
Immunisation Results 
Small molecular weight molecules or haptens such as domoic acid have limited 
immunogenicity and must be conjugated to a protein carrier to add immunogenicity. Previous 
studies indicated that the affinity of the produced antibody for the hapten changed according 
to the protein carrier used in the conjugation (Chu and Huang, 1992; Kawatsu et al 1999). In 
previous studies monoclonal antibodies for domoic acid have been raised to BSA, OVA, 
HGG and KLH for the immunization process (Kawatsu et al., 1999; Kania et al 2003; Le 
berre et al 2006, Tsao et al 2007) with success primarily for those conjugated to BSA and 
KLH.  However, bovine thyroglobulin, an established carrier protein for producing specific 
antibodies, had not previously been used for DA. In this work, the immunogen DA-BTG 
successfully produced an immune response in both mice and rabbits with increasing titres 
observed compared to before immunisation (Figure 3). For the five rabbits over the 6 month 
period, the trend in increasing response is typical for the immunisation schedule with a slight 
dip in response following the switch in adjuvant from Freunds complete to incomplete 
(between months 2 and 3). For the three immunised mice at month four, one mouse (Mouse 
2) showed an increase in response and had higher response than the rabbit counterparts and 
was thus selected for a further immunisation prior to harvesting the spleen for the fusion 
process. Compared to the first monoclonal antibody produced for DA (Kawatsu et al., 1999) 
this work showed that the conjugation ratio of toxin to protein can be reduced to 50% and the 
dose of immunogen to 20%. This may be crucial for other marine toxins when limited 
supplies of toxin are available for antibody production.    
 
Comparison of Techniques for Hybridoma Screening  
Mouse 2 was selected for fusion, as the titre for this mouse had the highest binding in the 
titre, SPR assays. The fusion process was successful, and the first line screening of 
hybridomas for antibodies against DA was compared by single channel Biacore Q biosensor, 
multiplex prototype SPR sensor, and ELISA. With these methods, 44 hybridomas screened 
positive by ELISA, 42 by the single channel biosensor and 43 by the multichannel biosensor, 
although each method had different positive hybridomas. On comparison, 22 out of 919 
hybridomas (2.3%) screened positive for all methods. Due to the multi spot (4 spots per 
channel) and four results per sample nature of the Biacore prototype (Campbell et al. 2011), 
this method offered increased sensitivity and repeatability of selection compared to the single 
channel Biacore Q. This prototype instrument can screen 96 samples (4×24) in 2 hours from 
loading of the instrument, whereas the Biacore Q takes over 12 hours for the same number of 
samples. Additionally, one ELISA plate, due in part to the overnight coating, takes a 
minimum of two days. Further, the re-usability of the Biacore chips offered 4-fold reduction 
in the use of toxin compared to the ELISA screening procedure.  
This efficiency in analysis time for routine monitoring for shellfish toxins is an advantage 
that was highlighted in addition to the use of this prototype instrument for the simultaneous, 
multiplex detection of marine toxins (Campbell et al. 2014). This system can therefore be 
extremely beneficial if there are large sample numbers to be analysed for the molecular 
interaction with the same target, but it would not be viably cost effective for small sample 
numbers. For hybridoma screening for antibody selection, this type of multiplexed, prototype 
instrument is very valuable, as the interactions can still be monitored in real-time and 
decisions can be made on the same day to proceed with the workload in hybridoma selection 
processes.  
 
Monoclonal Isotyping via the SPR Biosensor 
Following cloning, three hybridomas from the original Mouse 2 antibody were selected and 
monoclonal antibodies purified with protein concentrations Mono 1 = 1.16 mg/mL, Mono 2 = 
0.86 mg/mL, and Mono 3 = 1.35 mg/mL. On characterisation by isotyping, the heavy and 
light chains of the antibodies were IgG2a and k, respectively. The calibration curves (Figure 
4) and associated figures of merit (Table 1) for the three monoclonal antibodies and five 
polyclonal (rabbit) antibodies as run on the Biacore Q showed good sensitivity for the 
detection of domoic acid with an average IC50 at 5.6±1.2 ng/mL for the three monoclonal 
antibodies and 4.2±1.6 ng/mL for the five polyclonal antibodies. The sensitivity of the 
antibodies as assessed in the performance of the SPR biosensor assay was comparable to 
those used in different systems (Kania et al 2002; Tsao et al 2007) and improved by at least a 
factor of >100 for the monoclonal antibody compared to a previous SPR biosensor assays by 
other researchers (Le Berre et al 2006). It is important to note that for each of the antibody 
calibration curves there was a degree of non-specific binding on the chip surface of 
approximately 75-100 RU as seen in the high concentration binding levels and that the 
dynamic range for each of the curves varied. For example, Poly 5 has the lowest binding 
response but a large linear range (13.4 ng/mL based on IC80 minus the IC20). Poly 3 has a 
mid-binding response and the smallest linear range (4.9 ng/mL), whereas Poly 1 has the 
highest binding response with a mid-range linearity of 7.7 ng/mL. When choosing the best 
antibodies, these elements are taken into account and were utilised to identify Mono 2, as the 
antibody further studied due to good binding to the DA-chip of approx. 525 response units, 
9.7 ng/mL dynamic range, and longevity of supply and stability due to the monoclonal 
nature. 
 
Transferability to T100 Biacore 
Domoic acid, surface plasmon resonance assays have been performed by a number of groups, 
thus setting the stage for rapid, robust immunosensors for DA in shellfish. In Stevens et al., a 
portable SPR biosensor was developed for detection of DA down to 3 ppb in diluted clam 
extract with a surface capable of at least 50 regenerations (Stevens, 2007); however, this 
prototype SPR instrumentation had high standard deviations which could limit the utility for 
quantification. An immunosensor developed with a polyclonal antibody researched by 
Traynor et al. on a single-channel instrument allowed for up to 200 sample injections and 
shellfish DA concentrations compared well with LC-MS results (Traynor, 2006). 
Additionally, assays in buffer have been developed by a number of groups including those 
focusing on surface chemistry and assay development (Yu 2005), DA antibody screening (Le 
Berre, 2006), and novel molecularly imprinted polymer surfaces (Lotierzo, 2004). By 
employing these newly produced antibodies and designing a robust surface and assay on a 
commercial instrument, we are advancing biosensor technology to a potentially more broadly 
applicable platform for detecting DA in shellfish matrices. 
As shown, Mono 2 showed marginally better sensitivity on the Biacore Q instrument and was 
used for the comparison and evaluation on the Biacore T100. When using 50% 1:200 Ab 
mixed with the DA solutions, a raw response of 330 RU was observed for 0 ng DA/mL. For a 
90% 1:200 Ab assay, the raw response was 650 RU. Upon normalization to these values, a 
curve fit via a log (inhibitor) versus response, four parameter fit was obtained (GraphPad 
Prism v.5.02, La Jolla, CA, USA). As expected, and shown in Figure 5, the curve shapes are 
similar for each antibody percent but are shifted along the x-axis with the dynamic range for 
50% Ab from 6.0 to 31.2 ng/mL and that for the 90% Ab 33.1 to 226.6 ng/mL. Therefore, 
this approach of increasing the percentage of antibody can be used to desensitise the assay 
where necessary. Based on the extraction procedure used herein, 12.5 ng DA/mL is 
equivalent to the United States and European Union guidance levels of 20 µg DA/gram 
tissue. In order to obtain the best quantitative capability around this level, the 50% Ab 
mixture with an IC50 of 13.7 ng/mL was used for further assay evaluation. Additionally, this 
sensor surface for the T100 assay can be used for at least 311 cycles (per flow cell) with a 
maximum loss of 25% of the surface activity (~330 to ~250 RU). This signal decrease, 
however, did not result in a change to the normalized calibration curve, thus highlighting the 
robust and reusable nature of the SPR assay. 
 
Cross-reactivity 
The potential seafood toxin cross-reactors STX, TTX, and OA as well as the structurally 
similar GA, GluNH2, and AA did not show cross-reactivity to the anti-DA (0% cross-
reactivity), while kainic acid showed 24% cross-reactivity in comparison to domoic acid. 
Additionally, when mixtures of DA plus the cross-reactors were run, there was no significant 
difference in signal to that of 10 ng/mL DA alone, except in the case of KA plus DA. This 
reactivity is solely due to the aforementioned binding of KA to the surface creating additional 
signal. These effects are not unexpected, as DA and KA molecules are very similar in 
structure. Additionally, these results potentially indicate that the antibody is most reactive 
towards this area of the DA molecule. As KA is associated with a natural marine acid present 
in some seaweed and is not expected to occur with DA in shellfish samples, there should not 
be concern about false-positives in naturally contaminated seafood samples.  
Matrix Evaluation and Extraction Recovery 
Six matrices were chosen for evaluation, as these could potentially be contaminated with 
domoic acid: mussels, surfclams, oysters, scallops (gonad and viscera portions), and quahogs. 
The oysters (16 oz. wild caught with water added) and clams were purchased from a local 
vendor while the mussels, scallops and quahogs were harvested in 2007 from waters off the 
New England Coast of the United States and were determined in-house to be DA-free due to 
being at or below the blank measurement when using an ELISA.  
The raw response for the six matrices (0 ng DA/mL) and HBS-EP+ was between 308.2 to 
310.3 RU on Day 1 and 283.3 to 296.2 RU on Day 2. The values are slightly different 
between days, likely due to minor differences in antibody dilution, but are less than 2% 
different within a day. When normalized to their respective 0 ng DA/mL response, nearly 
identical overlap of the curves for each matrix are observed (Figure 6). This excellent overlap 
with the HBS-EP+ curve indicates that there are no obvious matrix effects. As there are no 
interferences from mussel, clam, oyster, scallop (gonad or viscera), and quahog matrices 
when using the 1 in 400 dilution necessary to have the action level near the centre of the 
linear range, there is no need to matrix match for the DA assay. As such, analysis can be 
significantly streamlined by having a singular buffer curve for quantitation of a variety of 
shellfish samples. To further evaluate this and determine DA recovery from the shellfish 
samples, an HBS-EP+ calibration curve was used to back calculate the concentration in the 
20 µg DA per 1 g tissue spikes. Each sample was analysed (n=3 per analysis) in duplicate. 
These initial studies show promise for this simple extraction method and the use of biosensor 
assays with this new antibody, as the extraction is efficient for each matrix (76% to 109%) as 
shown in Table 2. Additionally, there was little variation in the day one versus day two 
measurements as shown in Table 2 where the %CVs ranged from 2.01 to 6.45% for the six 
matrices. This further elucidates the robust nature of the SPR biosensor to yield repeatable 
results in sample analysis. 
 
Conclusions 
This work illustrated the application of three different SPR optical biosensors (high 
throughput Biacore prototype, Biacore Q and Biacore T100) in antibody production for their 
development and characterisation using domoic acid as a model target. The conjugation and 
immunization protocol developed herein for domoic acid applied lower toxin to protein ratios 
(50% less than previous methods) and thereby reduced the dose of immunogen by 20%. For 
antibody development and characterisation, the optical SPR biosensor offered the set-up of a 
simple assay design for real time evaluation of sensitivity, cross reactivity with structurally 
related compounds, as well as the effects of different shellfish matrices on the antibody-
analyte interaction. The multichannel biosensors offer enhanced speed for screening for 
suitable binders during monoclonal antibody selection. The assays developed herein for DA 
are, to our knowledge, the fastest and most sensitive SPR assays and can be used for over 300 
cycles with triplicate measurement per cycle. This study highlights that automated SPR 
biosensors can be effective tools for antibody characterisation, and these antibodies can then 
be employed for sensitive, robust DA detection in the diagnostics environment. Methods 
developed herein can be employed for further development of well-performing antibodies for 
toxin detection. 
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TABLE 1: Figures of merit for the monoclonal (Mono) and polyclonal (Poly) antibodies 
developed to the DA-BTG conjugate as analysed by the Biacore Q  
 
Domoic Acid Concentration (ng/mL) 
 
Mono 1 Mono 2 Mono 3 Poly 1 Poly 2 Poly 3 Poly 4 Poly 5 
IC20 1.6 1.6 2.2 1.7 0.9 0.7 1.5 1.8 
IC50 5.0 4.8 6.9 4.7 2.8 2.3 5.1 6.0 
IC80 11.8 11.3 16.6 9.4 6.9 5.6 12.8 15.2 
 
 
TABLE 2. Recovery analysis from shellfish matrices and the SPR assay. Concentration day 
one (Conc 1) is back calculated from GraphPad Prism and an HBS-EP+ curve (N=3 for all 
measurements) and similarly repeated on day 2 for Conc 2. 
Sample 
Calculated (ng/mL) 1g 4mL    
Conc 1 Conc 2 AVG SD %CV Tissue 
Extract 
Volume 
g/g 
tissue 
Spiked 
% 
Recovery 
Clam 8.54 9.14 8.84 0.42 4.77 1.02 4.4 15.3 20 76 
Mussel 11.7 12.82 12.26 0.79 6.45 1.02 4.5 21.6 20 108 
Oyster 8.54 8.81 8.68 0.19 2.17 0.99 4.4 15.4 20 77 
Viscera 9.87 10.52 10.2 0.46 4.50 1.00 4.4 17.9 20 90 
Gonad 10.58 10.89 10.73 0.22 2.01 0,99 4.4 19.1 20 95 
Quahog 12.49 13.23 12.86 0.52 4.08 1.01 4.3 21.9 20 109 
FIGURES 
Figure 1: Surface plasmon resonance (SPR) technology measures light reflection from the side of the chip opposite the flow channel. Upon 
antibody-toxin interaction at the chip surface, the change in reflected light angle (I to II) is detected. Each of the biosensors has different capacity 
for the simultaneous determination of toxin interaction on the surface due to the number of flow channels and detection points on each channel. 
 
Figure 2: Chip surface chemistry for the immobilisation of domoic acid onto the surface of 
CM5 SPR biosensor chips. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Evaluation of antibody titres for mice and rabbits each month over the 
immunisation period illustrated by the SPR response value obtained by the analysis of each 
sera at 1 in 50 dilution mixed in HBS-EP buffer each month. 
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Figure 4: Concentration analysis curves of response versus concentration for mouse derived 
monoclonal antibodies and each rabbit polyclonal antibody (1-5) (n = 2 for each data point 
with standard deviation less than the data point.) 
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Figure 5. Biacore T100 calibration curves of DA inhibition assay with new DA binding 
protein (Mono 2). (n=3 for each data point with standard deviation less than the data point.) 
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Figure 6. Biacore T100 calibration curves for DA-spiked shellfish matrices in comparison to 
DA-spiked buffer (n = 3 for each data point with standard deviation less than the data point.) 
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